In this review
Choose the service before judging the catalogue
The current product pages identify NAD+ and sermorelin injections alongside compounded semaglutide and tirzepatide. They establish separate advertised services, not a package of preventive visits, comprehensive tests and all prescriptions. A coming-soon peptide section elsewhere should not erase the specific current product pages or prove additional peptides are available. [1] [2] [3]
NAD+ shows $249 monthly or $600 billed every three months. Its complete formulation, supplied quantity and shipment cadence still need confirmation. The stylized vial is expressly not the actual label or size. I would identify the assigned clinician and dispensing pharmacy before valuing a particular prescription. [2]
Keep a measured marker separate from a health outcome with the biological-age testing evidence.
A defined follow-up makes a price meaningful
The care page describes physician messaging, a progress portal, supplies and refill delivery. It does not establish a complete included laboratory panel or scheduled preventive review. Ask which assessments and follow-up the proposed service requires, what can be booked and which costs sit outside the plan. [4]
Sermorelin’s panel says $199 monthly while its FAQ says $249; the selected three-month total is $559, with an approximate $186 monthly annotation. Semaglutide and tirzepatide also have monthly-label inconsistencies. Obtain the actual bill and renewal rather than add the smallest displayed figures into an imagined combined programme. [1] [3] [8] [9]
Separate visits, testing and actual prescriptions in the health-service cost planner.
Separate the next renewal from the current sale
Product FAQs say subscriptions charge automatically until cancellation through support. They do not set a precise notice period or establish a prorated refund. Confirm the intended cancellation date and actual order stages, particularly before prepaying three months. [2] [3]
The refund policy says all sales are final and prescription products cannot be returned for reuse or resale. Filling errors have a contact route, without an automatic refund or replacement promise. Neither that policy nor the website terms fully defines the financial result of medical nonapproval or a cancellation before preparation. Obtain those terms before submitting payment. [5] [7]
Compare another broad catalogue and purchase agreement in our Velvet Rx service-and-terms review.
Compare another recurring purchase and cancellation arrangement in our myRocky purchase-terms review.
Do not turn convenience into evidence of longer healthy life
Free-shipping advertising conflicts with policy language about checkout charges. The shipping policy also allows processing and transit delays. Generic warm-shipment stability statements should not replace storage and excursion advice for the actual pharmacy preparation. Service-specific terms qualify nationwide access claims too. [2] [4] [6] [7]
I would compare Vytora for a defined clinical service, rather than a general longevity promise. Compounded medicines are not FDA-approved. A larger menu, convenient messages or reported energy changes do not establish improved healthy lifespan, and evidence for weight treatment cannot simply be transferred to NAD+ or sermorelin. [1] [2] [3] [10]
Compare another defined preparation and follow-up arrangement in our KIN Meds service-scope review.
Understanding the cost
NAD+ $249 monthly/$600 each three months. Sermorelin panel $199 monthly versus FAQ $249; selected three-month total $559. Semaglutide $179 monthly/$447 three-month total with a conflicting monthly label; tirzepatide product $249 monthly/$599 three-month total versus homepage FAQ $199 monthly. Separate services, not a combined package.
Build your cost estimateSources
- Vytora: catalogue and homepage pricing FAQ
- Vytora: NAD+ product and selected monthly/three-month plans
- Vytora: sermorelin plans and conflicting monthly FAQ
- Vytora: messaging, portal and refill claims
- Vytora: complete prescription refund policy
- Vytora: processing, delivery and shipping charges
- Vytora: platform, clinical entities and eligibility terms
- Vytora: semaglutide and selected three-month billing
- Vytora: tirzepatide selected plans
- FDA: compounded drugs and premarket approval limits
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.